303 related articles for article (PubMed ID: 24387289)
1. Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis.
Chao DT; Lim JK; Ayoub WS; Nguyen LH; Nguyen MH
Aliment Pharmacol Ther; 2014 Feb; 39(4):349-58. PubMed ID: 24387289
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
[TBL] [Abstract][Full Text] [Related]
3. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
[TBL] [Abstract][Full Text] [Related]
4. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
[TBL] [Abstract][Full Text] [Related]
5. Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B.
Sanai FM; Helmy A; Bzeizi KI; Babatin MA; Al-Qahtani A; Al-Ashgar HA; Al-Mdani AS; Al-Akwaa A; Almutharea S; Khan MQ; Alghamdi AS; Farah T; Al-Hamoudi W; Saadeh M; Abdo AA
J Viral Hepat; 2011 Jul; 18(7):e217-25. PubMed ID: 21692936
[TBL] [Abstract][Full Text] [Related]
6. Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels.
Hu KQ; Schiff ER; Kowdley KV; Min AD; Shiffman ML; Lee WM; Goodman ZD; Dau LO; Peschell KJ; Fagan EA; Flaherty JF
J Clin Gastroenterol; 2010 Aug; 44(7):510-6. PubMed ID: 20179614
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography.
Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Am J Gastroenterol; 2008 Dec; 103(12):3071-81. PubMed ID: 19086958
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
[TBL] [Abstract][Full Text] [Related]
9. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA
J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
[TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
[TBL] [Abstract][Full Text] [Related]
11. Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase.
Wang J; Zhu L; Zhang Z; Zhang S; Pan Y; Li Y; Cao F; Jiang C; Fan T; Xiong Y; Liu J; Chen Y; Yin S; Tong X; Zhu C; Liu X; Li J; Wu C; Huang R
Virol J; 2024 Jun; 21(1):127. PubMed ID: 38835029
[TBL] [Abstract][Full Text] [Related]
12. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.
Jiang SW; Lian X; Hu AR; Lu JL; He ZY; Shi XJ; Zhu DD; Wang ZY; Huang GC
World J Gastroenterol; 2023 Apr; 29(16):2479-2494. PubMed ID: 37179582
[TBL] [Abstract][Full Text] [Related]
13. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.
Assy N; Beniashvili Z; Djibre A; Nasser G; Grosovski M; Nseir W
World J Gastroenterol; 2009 Jun; 15(24):3025-31. PubMed ID: 19554656
[TBL] [Abstract][Full Text] [Related]
14. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: Significant histological changes among treatment-naïve chronic hepatitis B patients with normal alanine aminotransferase levels by different criteria.
Li S; Shi L; Xu X; Wang H; You H; Jia J; Kong Y
Aliment Pharmacol Ther; 2023 Oct; 58(7):648-658. PubMed ID: 37551720
[TBL] [Abstract][Full Text] [Related]
16. Are there optimal alanine aminotransferase and HBV DNA thresholds for discriminating HBeAg-positive chronic infection from chronic hepatitis? An evaluation of 215 young and male cases.
Yenilmez E; Cetinkaya RA
Saudi Med J; 2019 Feb; 40(2):131-139. PubMed ID: 30723857
[TBL] [Abstract][Full Text] [Related]
17. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Wu IC; Lai CL; Han SH; Han KH; Gordon SC; Chao YC; Tan CK; Sievert W; Tanwandee T; Xu D; Neo BL; Chang TT
Hepatology; 2010 Apr; 51(4):1185-9. PubMed ID: 20044806
[TBL] [Abstract][Full Text] [Related]
19. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B.
Duan M; Chi X; Xiao H; Liu X; Zhuang H
Hepatol Int; 2021 Apr; 15(2):318-327. PubMed ID: 33638049
[TBL] [Abstract][Full Text] [Related]
20. Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients.
Jeng WJ; Sheen IS; Chen YC; Hsu CW; Chien RN; Chu CM; Liaw YF
Hepatology; 2013 Dec; 58(6):1888-96. PubMed ID: 23744454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
